A U.K. trade group is due to lift its suspension of Novo Nordisk, but critics cite a lack of transparency Academics ask whether the public will know if the company has substantively changed its business practices

https://www.statnews.com/pharmalot/2025/03/10/novo-weight-obesity-saxenda-wegovy-uk-marketing/